Status:
COMPLETED
Device for Bacteremia Prevention in Post Cardiac Surgical Intensive Care Unit Patients
Lead Sponsor:
Alison Fox-Robichaud
Collaborating Sponsors:
Dr. Richard Whitlock
Dr. Julian Owen
Conditions:
Infection
Heart; Surgery, Heart, Functional Disturbance as Result
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Intravenous catheters are often placed in large (central) veins in critically ill patients to provide special medications or frequent blood sampling. The body reacts to the presence of foreign materia...
Detailed Description
Randomization Randomization will be determined using an online random number generator. "www.randomize.net". The research coordinator will randomize the patients and provide bedside staff with the dev...
Eligibility Criteria
Inclusion
- 18-100 year old adult patients admitted to the ICU;
- Same-day admit to ICU;
- Post-op patient with central lines in situ (PICC, multi-lumen, side arm of introducer catheters or temporary dialysis lines), AND;
- Expected to have at least 1 central line in situ for more than 72 hrs.
Exclusion
- \>24hrs post-admittance to ICU
- Hopeless prognosis
- Currently admitted with known infection or suspicion of infection (i.e. known endocarditis or other infections).
- Chronic indwelling central venous catheters present
- Patients with known allergies to chlorhexidine
Key Trial Info
Start Date :
November 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03309137
Start Date
November 19 2017
End Date
November 30 2020
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Health Sciences
Hamilton, Ontario, Canada, L8L 2X2